Danielle Antalffy

Stock Analyst at UBS

(1.47)
# 1695
Out of 5,370 analysts
222
Total ratings
50.00%
Success rate
7.59%
Average return
43 Stocks
Name Action PT Current % Upside Ratings Updated
TMCI Treace Medical Conce...
Maintains: Neutral
10 9
5.74 49.83% 6 May 9, 2025
ATRC AtriCure
Maintains: Buy
60 58
32.24 79.9% 13 Apr 30, 2025
INMD InMode
Maintains: Neutral
19 17
13.42 21.09% 4 Apr 29, 2025
RXST RxSight
Downgrades: Neutral
45 16
14.06 13.8% 3 Apr 9, 2025
MDT Medtronic
Maintains: Neutral
85 95
87.94 8.03% 8 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
105 130
101.47 28.12% 11 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 5
4.22 18.48% 2 Jan 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
146 148
133.99 10.46% 12 Jan 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
182
100.5 81.09% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
366 370
376.8 -1.8% 6 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
90 75
74.71 0.39% 12 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
112 107
92.12 16.15% 4 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
163 95
83.28 14.07% 8 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
32.27 132.41% 1 Jan 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
180
155.09 16.06% 4 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
218
n/a n/a 4 Sep 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
405 322
129.39 148.86% 5 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
3
2.31 -2.6% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
43
30.74 39.88% 5 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
278
518.65 -46.4% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
45
20 125% 14 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
160 140
n/a n/a 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
300 280
305.89 -8.46% 12 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
975 825
20.59 3906.8% 2 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 20
n/a n/a 9 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 14
9.74 43.74% 1 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
75 100
77.64 28.8% 2 May 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 12
11.07 8.4% 3 Mar 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 30
60.59 -50.49% 3 Mar 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 65
n/a n/a 6 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 45
41.62 8.12% 4 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
105 85
n/a n/a 10 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 95
n/a n/a 6 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
270 275
172.18 59.72% 1 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
345 325
n/a n/a 12 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Market Perform
36 80
n/a n/a 1 Jan 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 20
3.25 515.38% 3 Nov 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
75 66
n/a n/a 4 Nov 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
72 42
6.57 539.27% 7 Nov 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
3
0.51 488.24% 3 Apr 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
15
1.25 1100% 1 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 75
n/a n/a 3 Oct 3, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Aug 22, 2017